Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Clinical trial NCT02826798 · COMPLETED
Trial details
- NCT number
- NCT02826798
- Sponsor
- VBI Vaccines Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-23
- Primary completion
- 2016-09-15
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.